pI: 9.6567 |
Length (AA): 465 |
MW (Da): 55073 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_130267)
Species | Accession | Gene Product |
---|---|---|
Dictyostelium discoideum | DDB_G0276103 | actin binding protein |
Drosophila melanogaster | Dmel_CG11449 | CG11449 gene product from transcript CG11449-RA |
Echinococcus granulosus | EgrG_001047400 | coiled coil domain containing 19 |
Echinococcus multilocularis | EmuJ_001047400 | coiled coil domain containing 19 |
Giardia lamblia | GL50803_13372 | Spindle pole protein, putative |
Homo sapiens | ENSG00000213085 | cilia and flagella associated protein 45 |
Leishmania braziliensis | LbrM.10.1260 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_101240.1 | Tumour suppressor, Mitostatin, putative |
Leishmania infantum | LinJ.10.1240 | hypothetical protein, conserved |
Leishmania major | LmjF.10.1150 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.10.1150 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000026546 | cilia and flagella associated protein 45 |
Neospora caninum | NCLIV_056330 | GI11378, related |
Schistosoma japonicum | Sjp_0003630 | Conserved hypothetical protein |
Schistosoma mansoni | Smp_172140 | hypothetical protein |
Schmidtea mediterranea | mk4.008934.04 | CCDC19 protein |
Schmidtea mediterranea | mk4.000702.07 | CCDC19 protein |
Schmidtea mediterranea | mk4.000101.09 | CCDC19 protein |
Schmidtea mediterranea | mk4.009249.05 | CCDC19 protein |
Trypanosoma brucei gambiense | Tbg972.8.4380 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.4580 | Basal body protein |
Trypanosoma congolense | TcIL3000_8_4420 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509571.50 | Basal body protein |
Trypanosoma cruzi | TcCLB.511409.50 | Basal body protein |
Toxoplasma gondii | TGME49_312980 | hypothetical protein |
Trichomonas vaginalis | TVAG_314720 | coiled-coil domain-containing protein, putative |
Trichomonas vaginalis | TVAG_397500 | splicing factor, arginine/serine-rich, putative |
Trichomonas vaginalis | TVAG_046480 | GRIP1-associated protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.4580 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.4580 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.4580 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.4580 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_312980 | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.